WO2023049693A3 - Formes posologiques pour l'administration d'un probiotique - Google Patents
Formes posologiques pour l'administration d'un probiotique Download PDFInfo
- Publication number
- WO2023049693A3 WO2023049693A3 PCT/US2022/076693 US2022076693W WO2023049693A3 WO 2023049693 A3 WO2023049693 A3 WO 2023049693A3 US 2022076693 W US2022076693 W US 2022076693W WO 2023049693 A3 WO2023049693 A3 WO 2023049693A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- delivery
- probiotic
- dosage forms
- infant
- compositions
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 241000186000 Bifidobacterium Species 0.000 abstract 1
- 210000002445 nipple Anatomy 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pediatric Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3233094A CA3233094A1 (fr) | 2021-09-24 | 2022-09-20 | Formes posologiques pour l'administration d'un probiotique |
CN202280064737.2A CN118042943A (zh) | 2021-09-24 | 2022-09-20 | 用于递送益生菌的剂型 |
JP2024518429A JP2024533678A (ja) | 2021-09-24 | 2022-09-20 | プロバイオティクスを送達するための剤形 |
EP22813000.1A EP4404771A2 (fr) | 2021-09-24 | 2022-09-20 | Formes posologiques pour l'administration d'un probiotique |
AU2022349055A AU2022349055A1 (en) | 2021-09-24 | 2022-09-20 | Dosage forms for the delivery of a probiotic |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163261581P | 2021-09-24 | 2021-09-24 | |
US63/261,581 | 2021-09-24 | ||
US17/933,174 US20230096810A1 (en) | 2021-09-24 | 2022-09-19 | Dosage forms for the delivery of a probiotic |
US17/933,174 | 2022-09-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2023049693A2 WO2023049693A2 (fr) | 2023-03-30 |
WO2023049693A3 true WO2023049693A3 (fr) | 2023-05-04 |
Family
ID=84362099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2022/076693 WO2023049693A2 (fr) | 2021-09-24 | 2022-09-20 | Formes posologiques pour l'administration d'un probiotique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023049693A2 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107259577A (zh) * | 2017-07-25 | 2017-10-20 | 李立风 | 益生菌凝胶粒及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1958031A (en) | 1931-04-27 | 1934-05-08 | Eugene L Bresson | Radio receiving system |
KR100574506B1 (ko) | 2004-02-26 | 2006-04-27 | 삼성전자주식회사 | 연산된 방위각의 오류여부를 표시하는 지자기센서 및 그방위각측정방법 |
IT1400821B1 (it) | 2009-03-09 | 2013-07-02 | Probiotical Spa | Sospensione oleosa contenente batteri probiotici per uso pediatrico |
US8198872B2 (en) | 2009-03-10 | 2012-06-12 | Honeywell International, Inc. | Starter-generator with improved excitation |
AU2011245768B2 (en) | 2010-04-26 | 2015-04-09 | Massey University | Emulsion |
TWI829098B (zh) | 2015-01-02 | 2024-01-11 | 美商梅拉洛伊卡公司 | 細菌組成物 |
EP3427839B1 (fr) | 2017-07-13 | 2020-12-02 | Aptar Radolfzell GmbH | Distributeur de liquide ayant une bouteille ventilée et une tête de distribution associée |
-
2022
- 2022-09-20 WO PCT/US2022/076693 patent/WO2023049693A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107259577A (zh) * | 2017-07-25 | 2017-10-20 | 李立风 | 益生菌凝胶粒及其制备方法 |
Non-Patent Citations (5)
Title |
---|
DATABASE GNPD [online] MINTEL; 10 August 2021 (2021-08-10), ANONYMOUS: "ProbioMed Infant Dietary Supplement", XP093017073, retrieved from https://www.gnpd.com/sinatra/recordpage/8926943/ Database accession no. 8926943 * |
DATABASE GNPD [online] MINTEL; 14 June 2019 (2019-06-14), ANONYMOUS: "Blueberry Probiotic Yoghurt", XP093017215, retrieved from https://www.gnpd.com/sinatra/recordpage/6629287/ Database accession no. 6629287 * |
DATABASE GNPD [online] MINTEL; 31 July 2020 (2020-07-31), ANONYMOUS: "Vitamin D Drops", XP093017219, retrieved from https://www.gnpd.com/sinatra/recordpage/7991911/ Database accession no. 7991911 * |
DATABASE GNPD [online] MINTEL; 6 July 2021 (2021-07-06), ANONYMOUS: "Multi-Vit + ProBio Gummies", XP093017208, retrieved from https://www.gnpd.com/sinatra/recordpage/8839399/ Database accession no. 8839399 * |
JENNIFER T. SMILOWITZ ET AL: "Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial", BMC PEDIATRICS, vol. 17, no. 133, 30 May 2017 (2017-05-30), pages 1 - 11, XP055583343, DOI: 10.1186/s12887-017-0886-9 * |
Also Published As
Publication number | Publication date |
---|---|
WO2023049693A2 (fr) | 2023-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Att et al. | Implant therapy to improve quality of life. | |
Guerra et al. | Platform switch versus platform match in the posterior mandible–1‐year results of a multicentre randomized clinical trial | |
Hong | Considerations in the pediatric population with cancer | |
Ettinger et al. | Abutment tooth loss in patients with overdentures | |
Konstantinidis et al. | Prospective evaluation of zirconia based tooth-and implant-supported fixed dental prostheses: 3-year results | |
Urdaneta et al. | A screwless and cementless technique for the restoration of single‐tooth implants: a retrospective cohort study | |
Goldstein et al. | Occlusal schemes for implant restorations: best evidence consensus statement | |
Chandu et al. | Management of Xerostomia and Hyposalivation in Complete Denture Patients. | |
Sanz‐Martín et al. | Randomized controlled clinical trial comparing two dental implants with different neck configurations | |
Ribeiro et al. | Dental implant rehabilitation of a patient with down syndrome: a case report | |
Maló et al. | Clinical outcomes in the presence and absence of keratinized mucosa in mandibular guided implant surgeries: a pilot study with a proposal for the modification of the technique. | |
Soardi et al. | Clinical and radiographic evaluation of immediately loaded one-piece implants placed into fresh extraction sockets | |
Lombardo et al. | Survival rates of ultra‐short (< 6 mm) compared with short locking‐taper implants supporting single crowns in posterior areas: a 5‐year retrospective study | |
Glibert et al. | Six-Year Radiographic, Clinical, and Soft Tissue Outcomes of Immediately Loaded, Straight-Walled, Platform-Switched, Titanium-Alloy Implants with Nanosurface Topography. | |
Ter Gunne et al. | Immediate and Early Loading of Two-Implant-Supported Mandibular Overdentures: Three-Year Report of Loading Results of a Single-Center Prospective Randomized Controlled Clinical Trial. | |
Huang et al. | Barriers Related to Dental Implant Treatment Acceptance by Patients. | |
WO2023049693A3 (fr) | Formes posologiques pour l'administration d'un probiotique | |
Kumar et al. | Removable partial denture supported by implants with prefabricated telescopic abutments-a case report | |
Khazaie et al. | Five‐Year Follow‐Up Treatment of an Ectodermal Dysplasia Patient with Maxillary Anterior Composites and Mandibular Denture: A Clinical Report | |
El-Amier et al. | Effect of implant location on palateless complete overdenture retention: preliminary study | |
Payer et al. | Immediate provisional restoration of XiVE® screw‐type implants in the posterior mandible | |
Shala et al. | Evaluation of sensibility threshold for interocclusal thickness of patients wearing complete dentures | |
Anchieta et al. | Root-supported overdenture as a prosthetic alternative for patients undergoing the transitional phase from partial to complete edentulism | |
Galganny-Almeida et al. | The use of chlorhexidine varnishes in children: what is out there? | |
Antoun et al. | Consecutive Case Series of Healed Single‐Molar Sites Immediately Restored with Wide‐Diameter Implants: A 1‐Year Evaluation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22813000 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3233094 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2024518429 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280064737.2 Country of ref document: CN |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112024005539 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: AU2022349055 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022813000 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022813000 Country of ref document: EP Effective date: 20240424 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11202402008Q Country of ref document: SG |
|
ENP | Entry into the national phase |
Ref document number: 2022349055 Country of ref document: AU Date of ref document: 20220920 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 112024005539 Country of ref document: BR Kind code of ref document: A2 Effective date: 20240320 |